November 3, 2025: Federal and State Courts Handling Depo-Provera Lawsuits Meet At an October 27, 2025, case management conference, the judge overseeing the federal Depo-Provera MDL met with judges from the New York and Delaware state courts
Click here or on the callout below for a full graphical representation of the data
By binding to these receptors, GLP-1 enhances insulin secretion from pancreatic -cells and suppresses glucagon secretion in a glucose-dependent manner, slows gastric emptying, and regulates appetite by increasing satiety and promoting a sense of fullness through its action on the hypothalamus [27, 28, 31,32,33]
Common side effects can include nausea, constipation, diarrhea, vomiting, stomach discomfort, or fatigue